Paper14739769
Matrix metalloproteinase inhibitor development and the remodeling of drug discovery.
Peterson JT. Heart Fail Rev, 2004. Cited by 155 papers, by iCite.
Cite this record
ConductScience Library. Matrix metalloproteinase inhibitor development and the remodeling of drug discovery. Papers, record 14739769. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14739769
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiomyopathy, Dilated | Major topic |
| Doxycycline | Major topic |
| Drug Design | Major topic |
| Enzyme Inhibitors | Major topic |
| Matrix Metalloproteinase Inhibitors | Major topic |
| Collagen | |
| Enzyme Activation | |
| Extracellular Matrix | |
| Humans | |
| Hydroxamic Acids | |
| Matrix Metalloproteinases | |
| Musculoskeletal Diseases | |
| Myocardium | |
| Neoplasms | |
| Periodontal Diseases |
Source PubMed
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10415745 | Thirty-six years in the clinic without an MMP inhibitor. What hath collagenase wrought? | Ann N Y Acad Sci | 1999 | https://conductscience.org/library/papers/10415745 | PubMed |
| 2 | 10713697 | The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. | Oncogene | 2000 | https://conductscience.org/library/papers/10713697 | PubMed |
| 3 | 11865675 | Increasing throughput in lead optimization in vivo toxicity screens. | Curr Opin Drug Discov Devel | 2002 | https://conductscience.org/library/papers/11865675 | PubMed |
| 4 | 12096249 | Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. | J Vasc Surg | 2002 | https://conductscience.org/library/papers/12096249 | PubMed |
| 5 | 7525108 | Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. | Circulation | 1994 | https://conductscience.org/library/papers/7525108 | PubMed |
| 6 | 11749499 | Design and therapeutic application of matrix metalloproteinase inhibitors. | Chem Rev | 1999 | https://conductscience.org/library/papers/11749499 | PubMed |
| 7 | 9724659 | Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. | EMBO J | 1998 | https://conductscience.org/library/papers/9724659 | PubMed |
| 8 | 12574145 | Selective matrix metalloproteinase inhibition with developing heart failure: effects on left ventricular function and structure. | Circ Res | 2003 | https://conductscience.org/library/papers/12574145 | PubMed |
| 9 | 11801860 | The use of fibrates and of statins in preventing atherosclerosis in diabetes. | Curr Opin Lipidol | 2001 | https://conductscience.org/library/papers/11801860 | PubMed |
| 10 | 12570684 | Drug discovery today. | Curr Top Med Chem | 2003 | https://conductscience.org/library/papers/12570684 | PubMed |
| 11 | 12571631 | Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3. | Gene Ther | 2003 | https://conductscience.org/library/papers/12571631 | PubMed |
| 12 | 10415734 | Preclinical and clinical studies of MMP inhibitors in cancer. | Ann N Y Acad Sci | 1999 | https://conductscience.org/library/papers/10415734 | PubMed |
| 13 | 666744 | Degradation of cartilage proteoglycans by a neutral proteinase secreted by rabbit bone-marrow macrophages in culture. | Biochem J | 1978 | https://conductscience.org/library/papers/666744 | PubMed |
| 14 | 8093070 | Tissue inhibitor of metalloproteinases (TIMP-1) stimulates the secretion of collagenase from human skin fibroblasts. | Biochem Biophys Res Commun | 1994 | https://conductscience.org/library/papers/8093070 | PubMed |
| 15 | 9590175 | MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. | Cell | 1998 | https://conductscience.org/library/papers/9590175 | PubMed |
| 16 | 12388239 | Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. | Am J Physiol Heart Circ Physiol | 2003 | https://conductscience.org/library/papers/12388239 | PubMed |
| 17 | 8910831 | Periodontal disease and cardiovascular disease. | J Periodontol | 1996 | https://conductscience.org/library/papers/8910831 | PubMed |
| 18 | 11060801 | Ongoing trials with matrix metalloproteinase inhibitors. | Expert Opin Investig Drugs | 2000 | https://conductscience.org/library/papers/11060801 | PubMed |
| 19 | 9288970 | Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. | Nature | 1997 | https://conductscience.org/library/papers/9288970 | PubMed |
| 20 | 11134178 | Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. | J Clin Invest | 2001 | https://conductscience.org/library/papers/11134178 | PubMed |
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 155 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42570066 | Kinetic and inhibitory profiling of serum MMP-9 in acute spinal cord injury: neurochemical links to injury severity and neuroinflammation. | Acta Neurol Belg | 2026 | https://conductscience.org/library/papers/42570066 | PubMed |
| 37108137 | Carborane-Containing Hydroxamate MMP Ligands for the Treatment of Tumors Using Boron Neutron Capture Therapy (BNCT): Efficacy without Tumor Cell Entry. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108137 | PubMed |
| 36982922 | New Drugs and Therapies in Pulmonary Arterial Hypertension. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982922 | PubMed |
| 36926709 | Reviving the use of inhibitors of matrix metalloproteases in spinal cord injury: a case for specificity. | Neural Regen Res | 2023 | https://conductscience.org/library/papers/36926709 | PubMed |
| 35925539 | Alpinumisoflavone against cancer pro-angiogenic targets: In silico, In vitro, and In ovo evaluation. | Daru | 2022 | https://conductscience.org/library/papers/35925539 | PubMed |
| 35742496 | Tetracyclines-An Important Therapeutic Tool for Dermatologists. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/35742496 | PubMed |
| 35441277 | Dolichoectasia: a brain arterial disease with an elusive treatment. | Neurol Sci | 2022 | https://conductscience.org/library/papers/35441277 | PubMed |
| 33396445 | The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors. | Pharmaceuticals (Basel) | 2020 | https://conductscience.org/library/papers/33396445 | PubMed |
| 33136210 | Tetracycline and viruses: a possible treatment for COVID-19? | Arch Virol | 2021 | https://conductscience.org/library/papers/33136210 | PubMed |
| 32958629 | Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-Myocardial Infarction Remodeling. | J Pharmacol Exp Ther | 2020 | https://conductscience.org/library/papers/32958629 | PubMed |
| 32233938 | Matrix Metalloproteinases and Glaucoma Treatment. | J Ocul Pharmacol Ther | 2020 | https://conductscience.org/library/papers/32233938 | PubMed |
| 31953328 | Selective inhibition of matrix metalloproteinase 10 (MMP10) with a single-domain antibody. | J Biol Chem | 2020 | https://conductscience.org/library/papers/31953328 | PubMed |
| 31653893 | Doxycycline reduces osteopenia in female rats. | Sci Rep | 2019 | https://conductscience.org/library/papers/31653893 | PubMed |
| 31213768 | Low-dose doxycycline inhibits hydrogen peroxide-induced oxidative stress, MMP-2 up-regulation and contractile dysfunction in human saphenous vein grafts. | Drug Des Devel Ther | 2019 | https://conductscience.org/library/papers/31213768 | PubMed |
| 29393911 | The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29393911 | PubMed |
| 28754718 | Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function. | Am J Physiol Heart Circ Physiol | 2017 | https://conductscience.org/library/papers/28754718 | PubMed |
| 28626528 | Exploitation of Conformational Dynamics in Imparting Selective Inhibition for Related Matrix Metalloproteinases. | ACS Med Chem Lett | 2017 | https://conductscience.org/library/papers/28626528 | PubMed |
| 28413032 | Matrix Metalloproteinases in Myocardial Infarction and Heart Failure. | Prog Mol Biol Transl Sci | 2017 | https://conductscience.org/library/papers/28413032 | PubMed |
| 27509041 | MMpI: A WideRange of Available Compounds of Matrix Metalloproteinase Inhibitors. | PLoS One | 2016 | https://conductscience.org/library/papers/27509041 | PubMed |
| 26269290 | The circular relationship between matrix metalloproteinase-9 and inflammation following myocardial infarction. | IUBMB Life | 2015 | https://conductscience.org/library/papers/26269290 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14739769
GET https://conductscience.org/api/papers/v1/14739769/references?page=2